Regeneron Pharmaceuticals, Inc. (REGN)
764.93
-22.57
(-2.87%)
USD |
NASDAQ |
Mar 05, 16:00
761.16
-3.77
(-0.49%)
Pre-Market: 08:20
Regeneron Pharmaceuticals Cash from Investing (Quarterly) : 220.30M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Eli Lilly & Co. | -2.802B |
| Merck & Co., Inc. | -11.20B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.171B |
| Cash from Financing (Quarterly) | -780.10M |
| Free Cash Flow | 3.765B |
| Free Cash Flow Per Share (Quarterly) | 8.186 |
| Free Cash Flow to Equity (Quarterly) | 612.80M |
| Free Cash Flow to Firm (Quarterly) | 889.87M |
| Free Cash Flow Yield | 4.53% |